Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy

NANot yet recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

March 1, 2027

Conditions
Atrial Fibrillation (AF)
Interventions
DEVICE

MEMO Patch 2 - 14-day Monitoring

A wearable ECG monitoring device used for continuous 14-day monitoring to detect atrial arrhythmias during the second monitoring phase (at 3 months post-ablation). MEMO Patch 2 collects ECG data for remote analysis to assess early recurrence of atrial arrhythmias.

DEVICE

MEMO Patch 2 - 1-day Monitoring

A wearable ECG monitoring device used for 1-day monitoring during the second monitoring phase (at 3 months post-ablation). MEMO Patch 2 collects ECG data for remote analysis to detect early recurrence of atrial arrhythmias.

DEVICE

MEMO Link

A supplementary ECG monitoring device used alongside MEMO Patch 2 during the 1st monitoring session.

Trial Locations (7)

13620

Seoul National University Bundang Hospital, Seongnam

49201

Dong-A University Hospital, Busan

49241

Busan National University Hospital, Busan

02855

Korea University Anam Hospital, Seoul

05505

Asan Medical Center, Seoul

07804

Ewha Womans University Seoul Hospital, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

HUINNO Co., Ltd

INDUSTRY

NCT06751459 - Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy | Biotech Hunter | Biotech Hunter